Jagiellonian University Repository

Non-CYP2D6 variants selected by a GWAS improve the prediction of impaired tamoxifen metabolism in patients with breast cancer

pcg.skipToMenu

Non-CYP2D6 variants selected by a GWAS improve the prediction of impaired tamoxifen metabolism in patients with breast cancer

Bibliographic description

Files in this item

This item appears in the following Collection(s)

Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa Except where otherwise noted, this item's license is described as Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa